IGF1R and diabetic kidney disease: Additionally, other IGF-1R inhibitors, including GSK4529, can ameliorate diabetic kidney disease by amelioration of inflammatory infiltration and tubulointerstitial fibrosis by suppressing Snail1 expression [29].